NRx Pharmaceuticals Advances in Breakthrough Bipolar Depression Treatment - MyChesCo
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently announced the completion of data collection in its pivotal Phase 2b/3 study of NRX-101. This milestone, known as data-lock, signifies the …
Timothy Alexander
